FS KKR Capital heads into its September-quarter report with a problem that sponsor support can soften but not erase. Wall Street expects net investment income of $0.40 per share, two cents below the 42-cent distribution management declared last quarter. That gap is small, but for a business development company whose payout has already dropped from 70 cents to 48 cents to 42 cents in three quarters, it raises the central question. Has the income base finally found a floor, or is another reset coming?
The consensus implies continued contraction rather than stabilization. Analysts are looking for revenue of roughly $281 million, down about 25% from a year ago and below the $290 million posted last quarter. Earnings per share are expected to fall nearly 30% year over year from $0.57. Much of that decline is deliberate. Management spent the past two quarters shrinking the portfolio to repair the balance sheet, using about $1.3 billion of repayments and around $500 million of loan sales to cut down its largest exposures. That brought leverage back inside the target range after it peaked at 138% gross debt-to-equity. The cost is a smaller pool of earning assets and a yield on accruing debt that has slipped from 10.5% to 9.7% over several quarters.
The previous call was calmer and more operational than the crisis-mode discussion that came before it. KKR's support package is now in motion. It includes a $300 million buyback that is active with the shares at a steep discount, a $150 million convertible preferred investment, and a 50% waiver of the subordinated incentive fee that runs for several more quarters. The fee waiver matters most this quarter because it is propping up net investment income. Investors should look at how much of the reported figure comes from the waiver and how much from underlying portfolio income. A beat that relies mostly on fee relief would say little about earnings power once the waiver ends.
Credit quality remains the swing factor. Non-accruals jumped to 8.1% of cost earlier this year, roughly double the industry norm. Last quarter brought fresh markdowns at PRG, ATX, Witter, Peraton, Lionbridge and Medallia, and management acknowledged that heavy lifting remains on non-income-producing assets. The narrative would be validated by a flat or lower non-accrual ratio, a smaller drop in net asset value, and evidence that the stressed healthcare roll-ups and government-contract borrowers are stabilizing. A new non-accrual name, more markdowns at Medallia or Peraton, or another meaningful NAV decline would challenge the idea that the worst is behind the company. Management also warned that repayments and M&A activity were running light this quarter. That may slow portfolio shrinkage but also limit fee income and the recycling of capital into the wider spreads now available on new deals, which management estimated at up to 75 basis points.
The market is not giving the company the benefit of the doubt. Shares have fallen 8.4% since the last report while the S&P 500 was flat. At $10.66, the stock trades below its 200-day moving average of $11.41, near the bottom of its post-earnings range of $10.05 to $12.71, and below the $11 price at which KKR ran its tender offer. Bearish sentiment has also deepened noticeably since the prior quarter. That pessimism lowers the bar for a relief rally, but it also shows how little patience is left for disappointments.
In the end, the report will be judged on whether net investment income can cover the 42-cent distribution with credit losses no longer eating into book value. If income holds near the payout and non-accruals stop rising, the self-help story starts to look like a turnaround. If the shortfall implied by consensus shows up alongside more markdowns, investors will reasonably conclude that the dividend has further to fall.